Appointment of Non-Executive Director

R&Q Insurance Holdings Ltd
30 June 2023
 

Logo Description automatically generated

 

R&Q Insurance Holdings Limited

 

Appointment of Non-Executive Director

 

30 June 2023

 

R&Q Insurance Holdings Ltd (AIM: RQIH) ("R&Q" or the "Group"), the leading non-life global specialty insurance company focusing on the Program Management ("Accredited") and Legacy Insurance ("R&Q Legacy") businesses, is pleased to announce that, in accordance with the Purchase and Exchange Agreement entered into with Scopia Capital Management, Scopia has nominated Jerome Lande as their representative to be appointed to the R&Q Board. The Board intends to appoint Jerome as a Non-Executive Director, subject to the satisfactory completion of due diligence checks typical for the appointment of a director of an AIM company. Assuming Jerome is appointed prior to the Annual General Meeting to be held on 28 July 2023, Jerome will stand for re-election at the Annual General Meeting.

 

-Ends-

 

 

 

Enquiries to:

 

R&Q Insurance Holdings Ltd


William Spiegel

Tel: +44 020 7780 5850

Tom Solomon

 

Numis Securities Limited (Nominated Advisor and Joint Broker)

Giles Rolls

Charles Farquhar

  

Tel: +44 020 7780 5850

 

 

 

Tel: +44 020 7260 1000

Tel: +44 020 7260 1000


FTI Consulting (Media Relations)

Tom Blackwell / Shipra Khanna

 

Tel: +44 020 3727 1051

 


Notes to Editors:

 

About R&Q 

 

R&Q is a global non-life specialty insurance company. We operate two core businesses: Program Management and Legacy Insurance. Both these businesses are leaders in their respective markets.

 

Our approach is to deploy our origination and underwriting capabilities, alongside our licensed and rated carriers in the US, EU, and the UK, to generate attractive fee returns in Program Management and Legacy Insurance.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings